5 ms·
Most of that article seems to be talking about an omicron wave, not delta. You were selective in your quote as that article states "we found higher levels of pr
by altacc 4y ago
Most of that article seems to be talking about an omicron wave, not delta. You were selective in your quote as that article states "we found higher levels of protection among those who received two doses of BNT162b2 compared with those who received two doses of CoronaVac", which supports my claim, given that 2 doses was the initial recommended schedule.
Regardless, unless they are large and well conducted systemic reviews, single articles and studies are not enough to represent reality or for either of us to derive conclusions. Good science is slow, much slower than needed for policy decisions.
- FooBarWidget 4y agoI'm being selective? Why would you compare 2-dose efficacy when the point is that 3-dose efficacy is similar? W.r.t. Omicron, the Dutch govt is very clear about the fact 2-dose Pfizer is not enough and that you need boosters, which makes insisting on a 2-dose comparison even stranger. Agreed on more research being needed. But the opposite also holds: concluding that Chinese vaccines don't work, especially when such conclusion is usually used to support the implicit thesis that "our vaccines work great and they're in this mess because they didn't use ours", is also irresponsible.